Are there registered clinical trials (ClinicalTrials.gov) for any consumer nootropic called Memo Blast or similar brand names?
Executive summary
No clinicaltrials.gov registration was found for any consumer product explicitly named “Memo Blast” in the supplied reporting; the only ClinicalTrials.gov identifier in the dataset (NCT04790188) corresponds to a different commercial multi-ingredient nootropic (Evo‑Gamers®) as documented in a peer‑reviewed article (Frontiers) and the ClinicalTrials.gov record itself [1] [2]. There is, however, an older randomized trial of a distinct supplement called “Memo®” (not Memo Blast) reported on PubMed Central, showing clinical study activity for that specific formulation [3].
1. ClinicalTrials.gov evidence: the one registry entry in these sources is not Memo Blast
The only ClinicalTrials.gov identifier surfaced in the material is NCT04790188, and the Frontiers article explicitly ties that registration to a dietary multi‑ingredient nootropic sold as Evo‑Gamers® and describes the randomized, triple‑blinded crossover trial of that product in young adults [1], while the raw ClinicalTrials.gov reference appears among the search snippets [2]. Nowhere in the supplied registry or the Frontiers paper is “Memo Blast” named as the investigational product, so the dataset does not support a claim that Memo Blast has a ClinicalTrials.gov trial record [1] [2].
2. Another similarly named product—“Memo®”—has peer‑reviewed trial data, but it’s a different formulation
A randomized study of a marketed dietary supplement called Memo® (distinct from Memo Blast) was published and is archived on PubMed Central; that trial enrolled 66 subjects with mild cognitive impairment and reported statistically significant improvements in MMSE scores for the Memo® group versus placebo over four weeks [3]. The study describes Memo® as a specific combination—including royal jelly and standardized extracts—so this establishes that a product with the similar name “Memo” has been clinically tested, but it is not evidence that the consumer‑market Memo Blast brand was included in that research [3].
3. Manufacturer and retail claims for Memo Blast exist, but they are marketing claims, not registry entries
Multiple commercial sources and the Memo Blast websites promote the product as a “clinically researched” or “science‑backed” natural nootropic and market it for memory and focus [4] [5], and major retail listings show Memo Blast sold as a consumer supplement [6] [7] [8]. Those marketing statements are present in the supplied material, but the material does not include a ClinicalTrials.gov registration linking Memo Blast to a trial, so the promotional language stands uncorroborated by the registry evidence provided [4] [5] [6].
4. Independent reporting and reviews raise safety and transparency questions for consumer Memo Blast products
A consumer review source included in the dataset reports adverse experiences and accuses the product of inconsistent labeling and deceptive practices, illustrating at least one strand of consumer skepticism about Memo Blast and underscoring transparency concerns that commonly arise when marketing claims outpace publicly registered clinical data [9]. The existence of retail listings and promotional sites [6] [5] explains why consumers may assume clinical validation, yet the supplied sources do not bridge that assumption to a ClinicalTrials.gov record for this brand.
5. What this collection of sources supports — and what it does not
Supported: a ClinicalTrials.gov‑registered trial exists for a multi‑ingredient nootropic identified in the literature as Evo‑Gamers® (NCT04790188) [1] [2], and an older randomized trial exists for a separate supplement named Memo® [3]. Not supported by the provided reporting: any ClinicalTrials.gov registration that explicitly names “Memo Blast” or ties that brand to a registered clinical trial (no such registry entry appears in the supplied snippets) [2] [4] [5]. If a definitive registry search beyond these supplied sources is required, that would be the next step; the current reporting does not contain a ClinicalTrials.gov entry for Memo Blast.
Conclusion
Within the supplied reporting, there is no ClinicalTrials.gov registration for a consumer nootropic explicitly called “Memo Blast”; the only registry identifier presented (NCT04790188) relates to Evo‑Gamers® [1] [2], and a different product named Memo® has a published randomized trial [3]. Promotional materials claim “clinically researched” ingredients for Memo Blast [4] [5], but those claims are not corroborated by the ClinicalTrials.gov evidence included here [2].